HIV positive employees face unemployment and workplace discrimination, indicates a study published ahead of print in Occupational and Environmental Medicine. But women and those who are less well educated are the most vulnerable, the research shows.
The fight against the deadly tropical disease Leishmaniasis, also known as black fever, has been boosted by scientists at the University of Durham, whose new screening system has raised the possibility of new, safer drugs.
Swedish researchers have discovered that oseltamivir (Tamiflu); an antiviral drug used to prevent and mitigate influenza infections is not removed or degraded during normal sewage treatment. Consequently, in countries where Tamiflu is used at a high frequency, there is a risk that its concentration in natural waters can reach levels where influenza viruses in nature will develop resistance to it.
PLoS ONE publishes a study showing that inhalation of carbon dioxide (CO2) triggers emotional distress and a panic response in healthy individuals. The findings of the study posit panic as an inborn survival-oriented response. The results may be relevant for a better understanding and the further prevention of emotional disorders.
A summary of evidence on the diagnosis and treatment of low-back pain has prompted the American Pain Society (ASP) and the American College of Physicians (ACP) to issue a new treatment guideline. The guideline is based on a thorough analysis of published research conducted by investigators at the Oregon Evidence-Based Practice Center at Oregon Health & Science University.
A new knee-surgery device investigated by University of Missouri-Columbia researchers that will help to repair meniscus tears, which were previously defined as irreparable, has been approved by the FDA for use in humans.
Men with certain scores and patterns based on prostate cancer biopsy were found to be at higher risk of PSA-failure, suggesting that this measurement could help predict the risk of prostate cancer recurrence, according to preliminary research published in the Oct. 3 issue of JAMA.
In people with chronic myeloid leukemia (CML), the drug Imatinib has been shown to drive cancer into remission, but the disease often returns when treatment is stopped. New research by UC Irvine scientists indicates that Imatinib could cure CML under certain circumstances if it is taken over a long enough period of time.
University of Manchester scientists will discuss their research aimed at reducing the side effects of radiotherapy without decreasing its effectiveness at the National Cancer Research Institute conference in Birmingham today Tuesday, Oct. 2, 2007.
The routine vaccination of children against Human Papilloma Virus (HPV) – the first adolescent vaccine against a sexually transmitted infection – will be discussed at the National Cancer Research Institute conference in Birmingham today (1515hrs, Tuesday 2 October).